This raises the question as to whether IFN hypersensitivity with an increased expression of IFN receptors on immunocytes capable of inducing phosphorylation and/or abnormal splicing of tau protein is a factor in cases of AD and other neurodegenerative diseases in the absence of DS/T21, thereby qualifying it as an autoimmune disease. This evidence concerns the gene MAPT and neurodegenerative disease.